登录

VCBeat launches its first ever report on global DTx industry

作者: 陈鹏 2022-05-29 09:47

In recent years, DTx (Digital Therapeutics) has attracted industry attention and gained wide recognition for its unique advantages. As the first media organization to follow DTx in China, VCBeat (vbdata.cn) started to focus on DTx as early as 2016 and has been striving to promote the industry in the way we know best. To date, VCBeat has published hundreds of articles on DTx. We have alsopublished China Digital Therapeutics Industry White Paper (2021) and China Digital Therapeutics White Paper 2.0, which has made  a far-reaching  impact and greatly promoted the development of the industry.


There is no doubt that the DTx industry is growing much faster than expected. Therefore, VCBeat also continues to follow the industry trend today, officially releasing the Global Digital Therapeutics Industry Report (2022). The report is jointly released by VCBeat and Hainan Provincial Health Commission, with the assistance of industry partners - The Digital Therapeutics Committee of China Association for Medical Devices Industry as the consultant; dozens of organizations in the industry are involved in compiling the report. The report aims to present a comprehensive and timely picture of the development and exploration of DTx globally and domestically, and to provide a reference for the development of the industry.


DTx has now received a great deal of attention from the healthcare industry. Pioneering regions of China are also exploring in various ways. For example, Hainan province is the first to include DTx in its provincial plan. The joint release of the Global Digital Therapeutics Industry Report (2022) by VCBeat and Hainan Provincial Health Commission also represents the consistent attention to DTx in Hainan province. Zhang Yuhui, deputy director of Hainan Provincial Health Commission, said in this regard: "The development of DTx industry is in line with the central government's requirements for Hainan's innovative and high-quality development, and is an important path for Hainan to accelerate the construction of a patient-centered healthcare system and enhance the health and well-being of Hainan people, as well as a new engine for the high-quality development of Hainan's healthcare industry. Hainan will seize the historical opportunity to promote the DTx industry to gather and develop in Hainan, andgive wings to Hainan's healthcare system development with intelligent medical service."


The report’s content is shown as follows:


Table of Contents


1. Overview of Digital Therapeutics

   1.1 Definition and key features of Digital Therapeutics

       1.1.1 Definition of Digital Therapeutics

       1.1.2 Key features of Digital Therapeutics

   1.2 Pain points solved by Digital Therapeutics

       1.2.1 Patients

       1.2.2 Healthcare providers

       1.2.3 Payers

       1.2.4 Pharmaceutical enterprises

   1.3 Technology-empowered Digital Therapeutics

       1.3.1 Artificial intelligence

       1.3.2 IoT

       1.3.3 Cloud computing and big data

       1.3.4 Virtual, augmented and mixed reality

       1.3.5 Low-code development

2. Current situation of global Digital Therapeutics industry

   2.1. Rise of Digital Therapeutics around the world

       2.1.1. United States

       2.1.2. Europe

       2.1.3. Japan

       2.1.4. South Korea

   2.2. Global policy promotion of Digital Therapeutics

   2.3 Global industry clusters for Digital Therapeutics

   2.4  Forecast of global Digital Therapeutics market size

   2.5  Business model of global Digital Therapeutics

   2.6  Investment and financing analysis of global Digital Therapeutics

   2.7 Global approval of Digital Therapeutics

       2.7.1 Specific approval policy of Digital Therapeutics

       2.7.2 Approval status

   2.8 Global Digital Therapeutics organizations

3. What Hainan Does in the field of Digital Therapeutics Industry

 

Click to download the report for free


注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

陈鹏

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

阿斯利康75亿交易达成

【首发】独家专访“岷山行动”杨寒朔,联合君联资本孵化 “臻愈生物”并完成种子轮融资

药明、荣昌、昆翎、嘉实重仓的药企今日IPO,6年融资约14亿

北京首张!艺妙神州获批CAR-T 细胞治疗产品《药品生产许可证》

陈鹏

共发表文章202篇

最近内容
  • 史上最惨,损失已超50亿美元,医疗行业必须做好这件事

    3 天前

  • 互联网医疗巨头走到退市边缘

    2024-04-16

  • 8年提升1000倍AI性能,NVIDIA重注医疗

    2024-04-11

上一篇

《数字疗法全球报告(2022)》发布,近十万字最全记录行业探索

2022-05-29
下一篇

可扩展算法用于血流动力学仿真计算,阿特瑞如何实现心脑血管疾病的个性化诊断?

2022-05-30